10 insiders reported 231 Form 4 transactions for LIGAND PHARMACEUTICALS INC (LGND) over the past 18 months (most recent 2026-08-14). Recent activity: Espinoza Octavio (Chief Financial Officer) Buy 16,179 shares, Haas Jason (Director) Buy 6,138 shares, Haas Jason (Director) Sell 7,138 shares, Espinoza Octavio (Chief Financial Officer) Buy 2,074 shares, Espinoza Octavio (Chief Financial Officer) Buy 2,869 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | Espinoza Octavio | Chief Financial Officer | Buy | 16,179 | $854,898 |
| 2026-08-14 | Haas Jason | Director | Buy | 6,138 | $316,475 |
| 2026-08-14 | Haas Jason | Director | Sell | 7,138 | $2.1M |
| 2026-08-14 | Espinoza Octavio | Chief Financial Officer | Buy | 2,074 | $145,263 |
| 2026-08-14 | Espinoza Octavio | Chief Financial Officer | Buy | 2,869 | $159,947 |
| 2026-08-14 | Espinoza Octavio | Chief Financial Officer | Buy | 7,171 | $410,325 |
| 2026-08-14 | Espinoza Octavio | Chief Financial Officer | Buy | 3,348 | $230,142 |
| 2026-08-14 | Espinoza Octavio | Chief Financial Officer | Sell | 31,641 | $9.2M |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Sell | 1,032 | $295,974 |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Sell | 105 | $29,834 |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Sell | 33 | $9,390 |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Sell | 157 | $44,861 |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Buy | 5,000 | $261,350 |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Sell | 1,214 | $349,357 |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Sell | 503 | $145,771 |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Sell | 200 | $58,120 |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Sell | 991 | $289,086 |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Sell | 409 | $119,763 |
| 2026-08-04 | Reardon Andrew | CLO & Secretary | Sell | 356 | $102,795 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Sell | 104 | $32,261 |
| 2026-07-06 | Davis Todd C | Chief Executive Officer | Buy | 132 | $21,214 |
| 2026-07-06 | Espinoza Octavio | Chief Financial Officer | Buy | 17 | $2,732 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Buy | 132 | $21,214 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Buy | 5,000 | $261,350 |
| 2026-07-06 | Reardon Andrew | CLO & Secretary | Sell | 396 | $122,359 |
Source: SEC Form 4 filings · as of 2026-08-14